All Industries

Top Drug Discovery Companies

1,077 Drug Discovery companies, sorted by total funding raised.

Plexium

Next-generation targeted protein degradation biotech company developing monovalent degraders for ...

San Diego, United States51–200Biotech, Drug Discovery
Venture RoundTotal funding$197.1MAug 2025
Aera Therapeutics

Biotechnology company developing next-generation genetic medicines using a proprietary protein na...

Boston, United States51–200Biotech, Drug Discovery
Series ATotal funding$193.0MFeb 2023
Centrexion Therapeutics

Centrexion Therapeutics Corp. is focused on advancing the treatment of chronic moderate to severe...

Boston, United States11–50Biotech, Drug Discovery
Venture RoundTotal funding$192.4MJun 2023
SpliceBio

SpliceBio develops next-generation gene therapies using its proprietary Protein Splicing platform...

Barcelona, Spain11–50Biotech, Drug Discovery
Series BTotal funding$192.0MJun 2025
Hexagon Bio

Biopharmaceutical company using genomics, computation, and synthetic biology to discover microbia...

Menlo Park, United States51–200Biotech, Drug Discovery
Series CTotal funding$185.3MFeb 2023
Jasper TherapeuticsIPO

Clinical-stage biotechnology company developing briquilimab, a monoclonal antibody targeting c-Ki...

Redwood City, United StatesBiotech, Drug Discovery
Private EquityTotal funding$181.0MAug 2026
Verge Genomics

Verge builds AI systems using proprietary patient brain data to help drug developers identify tar...

South San Francisco, United States11–50Biotech, Drug Discovery
Corporate RoundTotal funding$176.1MSep 2023
Numab

Numab designs and develops a new class of powerful therapeutics for the treatment of severe disea...

Biotech, Drug Discovery
Extension RoundTotal funding$165.0MJan 2025
Addex TherapeuticsIPO

Addex Therapeutics is a biopharmaceutical company focused on the development of novel, orally ava...

Plan-les-Ouates, Switzerland11–50Biotech, Drug Discovery
Extension RoundTotal funding$155.9MAug 2022
Moonwalk Biosciences

Develops precision epigenetic medicines targeting adipose biology and cardiometabolic disease usi...

South San Francisco, United States11–50Biotech, Drug Discovery
Series BTotal funding$155.5MSep 2026
EpizymeIPO

Biopharmaceutical company that is creating innovative drugs for major diseases based on important...

Cambridge, United States201–500Biotech, Drug Discovery
Growth EquityTotal funding$154.0MNov 2019
Sagimet BiosciencesIPO

A clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat impo...

San Mateo, United States11–50Biotech, Drug Discovery
Growth EquityTotal funding$153.5MFeb 2021
ElektrofiAcquired

Develops Hypercon hyper-concentrated microparticle formulations to enable subcutaneous delivery o...

Boston, United States51–200Life Sciences, Biotech
Series CTotal funding$152.3MOct 2024
Congruence Therapeutics

Congruence Therapeutics discovers small-molecule correctors and allosteric modulators that restor...

Montreal, Canada11–50Biotech, Drug Discovery
Series BTotal funding$137.0MMar 2026
Pretzel Therapeutics

Develops therapeutics that restore mitochondrial function for rare and common diseases using geno...

Waltham, United States11–50Biotech, Drug Discovery
Venture RoundTotal funding$131.8MAug 2024
CHARM Therapeutics

AI-driven biotech developing next-generation menin inhibitors and small-molecule therapeutics for...

London, United Kingdom11–50Life Sciences, Biotech
Series BTotal funding$130.0MSep 2025
Nautilus BioIPO

Biotechnology company developing a single-molecule proteomics platform to identify and quantify p...

San Diego, United States51–200Biotech, Artificial Intelligence
Corporate RoundTotal funding$128.3MJul 2021
Monte Rosa TherapeuticsIPO

Monte Rosa Therapeutics is a clinical-stage biotechnology company developing molecular glue degra...

Boston, United States51–200Biotech, Drug Discovery
Series CTotal funding$127.5MMar 2021
FT
Forma TherapeuticsAcquired

Clinical-stage company focused on rare hematologic diseases and cancers; acquired by Novo Nordisk...

United States51–200Biotech, Healthcare
Series DTotal funding$125.5MDec 2019
Gate Bioscience

Biotechnology company developing oral small-molecule ‘molecular gates’ to eliminate disease-causi...

California, United States11–50Biotech, Drug Discovery
Series BTotal funding$125.0MNov 2025
Alexza PharmaceuticalsAcquired

Alexza Pharmaceuticals, now operating as Nova Pneuma, developed Staccato One Breath Technology an...

Mountain View, United States51–200Biotech, Drug Discovery
Series DTotal funding$124.5MJul 2012
Ouro Medicines

Biotechnology company dedicated to developing immune reset therapeutics for people living with ch...

USA, United States11–50Biotech, Drug Discovery
Series ATotal funding$120.0MJan 2025
Acreage HoldingsIPO
Cannabis, Drug Discovery
Series ETotal funding$119.0MJul 2018
Healx

AI-enabled biotech using generative AI to discover and develop treatments for rare diseases, adva...

Cambridge, United Kingdom51–200Artificial Intelligence, Biotech
Series CTotal funding$114.5MAug 2024
XilisClosed

Develops MicroOrganoSphere ex vivo tumor models and AI analytics to guide precision oncology and ...

Durham, United States51–200Biotech, Diagnostics
Series ATotal funding$111.0MApr 2025